Somatostatin analogues in the treatment of endocrine tumours of the gastrointestinal tract

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.6, 2002-06, pp. : 643-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib Mesylate: In the Treatment of Gastrointestinal Stromal Tumours

By Croom K.F. Perry C.M.

Drugs, Vol. 63, Iss. 5, 2003-01 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?

By Nilsson Bengt Nilsson Ola Ahlman Håkan

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 457-468

Informa Healthcare

Access to resources Recommend Favorite

Use of Somatostatin Analogues in Obesity

By Tzotzas Themistoklis

Drugs, Vol. 68, Iss. 14, 2008-01 ,pp. : 1963-1973

Adis International

Access to resources Recommend Favorite

Therapeutic applications of somatostatin analogues

By Ösapay G. Ösapay K.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 855-870

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours

By Huse Daniel M.

Clinical Drug Investigation, Vol. 27, Iss. 2, 2007-01 ,pp. : 85-93

Adis International

Access to resources Recommend Favorite